CompletedPhase 2NCT01403896
Healthy Donor Study II - Comparing Plerixafor With G-CSF and Plerixafor
Studying Isolated femoral agenesis/hypoplasia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Stephen Couban
- Principal Investigator
- Stephen CoubanCDHA
- Intervention
- Plerixafor (Mozobil)(drug)
- Enrollment
- 10 target
- Eligibility
- 18-30 years · All sexes
- Timeline
- 2012 – 2015
Study locations (1)
- Capital Health District Authority, Halifax, Nova Scotia, Canada
Collaborators
Genzyme, a Sanofi Company
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01403896 on ClinicalTrials.govOther trials for Isolated femoral agenesis/hypoplasia
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT07539792Efficacy and Safety Evaluation of Absorbable and Moldable Skull Base Support Plates in Extended Endoscopic Endonasal Transsphenoidal Surgery: A Prospective, Randomized, Controlled StudyNanfang Hospital, Southern Medical University
- ACTIVE NOT RECRUITINGNCT07151794G8, CARG, Frailty, and Nutritional Markers in Predicting ChemotoxicityÇanakkale Onsekiz Mart University
- RECRUITINGEARLY PHASE1NCT06216938RP1 in Primary Melanoma to Reduce the Risk of Sentinel Lymph Node MetastasisYana Najjar
- RECRUITINGNCT06164483Auditory Functions in Patients With Multiple SclerosisUniversity of Catania
- RECRUITINGPHASE2NCT05817214Cadonilimab Plus Anlotinib for R/M/P Cervical CancerZhongnan Hospital
- ENROLLING BY INVITATIONNANCT04498026Adherus™ Dural Sealant in Spinal ProceduresStryker Craniomaxillofacial
- RECRUITINGNANCT04099823MR Evaluation of Cerebrospinal Fluid (CSF) DynamicsMayo Clinic
- RECRUITINGPHASE1, PHASE2NCT03866525OH2 Oncolytic Viral Therapy in Solid TumorsBinhui Biopharmaceutical Co., Ltd.